Concepedia

Xu-Shan Tang

XT

Statistics

Publications

2

Citations

63

H-Index

2

Active since

2016

Affiliations

Xinjiang Medical University(Current)

Xu-Shan Tang is an author at Xinjiang Medical University specializing in clinical efficacy, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2018

2

Publications

2

UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer

Chunlei Xu, Xu-Shan Tang, Yanli Qu et al. · Cancer Chemotherapy and Pharmacology · 2016 · 52 citations

, , +8

MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)

Na Li, Mei Han, Ning Zhou et al. · Medical Science Monitor · 2018 · 11 citations · Full text

1–2 of 2